[PDF][PDF] Decreased consumption of branched-chain amino acids improves metabolic health

…, EL Baar, N Veronese, SE Cottrell, RJ Fenske… - Cell reports, 2016 - cell.com
Protein-restricted (PR), high-carbohydrate diets improve metabolic health in rodents, yet the
precise dietary components that are responsible for these effects have not been identified. …

Restoration of metabolic health by decreased consumption of branched‐chain amino acids

…, ME Barnes, JA Wisinski, RJ Fenske… - The Journal of …, 2018 - Wiley Online Library
Key points We recently found that feeding healthy mice a diet with reduced levels of
branched-chain amino acids (BCAAs), which are associated with insulin resistance in both humans …

Phenotypic Characterization of MIP-CreERT1Lphi Mice With Transgene-Driven Islet Expression of Human Growth Hormone

…, V Bergeron, JC Neuman, HK Brar, RJ Fenske… - Diabetes, 2015 - Am Diabetes Assoc
There is growing concern over confounding artifacts associated with β-cell–specific Cre-recombinase
transgenic models, raising questions about their general usefulness in research. …

Enriching Islet Phospholipids With Eicosapentaenoic Acid Reduces Prostaglandin E2 Signaling and Enhances Diabetic β-Cell Function

JC Neuman, MD Schaid, AL Brill, RJ Fenske… - Diabetes, 2017 - Am Diabetes Assoc
Prostaglandin E 2 (PGE 2 ) is derived from arachidonic acid, whereas PGE 3 is derived from
eicosapentaenoic acid (EPA) using the same downstream metabolic enzymes. Little is …

Radiomanganese PET detects changes in functional β-cell mass in mouse models of diabetes

…, SA Graves, T Gregg, HR VanDeusen, RJ Fenske… - Diabetes, 2017 - Am Diabetes Assoc
The noninvasive measurement of functional β-cell mass would be clinically valuable for
monitoring the progression of type 1 and type 2 diabetes as well as the viability of transplanted …

[HTML][HTML] Plasma Prostaglandin E2 Metabolite Levels Predict Type 2 Diabetes Status and One-Year Therapeutic Response Independent of Clinical Markers of …

RJ Fenske, AM Weeks, M Daniels, R Nall, S Pabich… - Metabolites, 2022 - mdpi.com
Over half of patients with type 2 diabetes (T2D) are unable to achieve blood glucose targets
despite therapeutic compliance, significantly increasing their risk of long-term complications. …

[HTML][HTML] Systemic Metabolic Alterations Correlate with Islet-Level Prostaglandin E2 Production and Signaling Mechanisms That Predict β-Cell Dysfunction in a Mouse …

…, NE Richardson, C Patibandla, IM Ong, RJ Fenske… - Metabolites, 2021 - mdpi.com
The transition from β-cell compensation to β-cell failure is not well understood. Previous
works by our group and others have demonstrated a role for Prostaglandin EP3 receptor (EP3), …

Metformin monotherapy alters the human plasma lipidome independent of clinical markers of glycemic control and cardiovascular disease risk in a type 2 diabetes …

B Wancewicz, Y Zhu, RJ Fenske, AM Weeks… - … of Pharmacology and …, 2023 - ASPET
Type 2 diabetes (T2D) is a rising pandemic worldwide. Diet and lifestyle changes are typically
the first intervention for T2D. When this intervention fails, the biguanide metformin is the …

The Inhibitory G Protein α-Subunit, Gαz, Promotes Type 1 Diabetes-Like Pathophysiology in NOD Mice

RJ Fenske, MT Cadena, QE Harenda… - …, 2017 - academic.oup.com
The α-subunit of the heterotrimeric G z protein, Gα z , promotes β-cell death and inhibits β-cell
replication when pancreatic islets are challenged by stressors. Thus, we hypothesized that …

Exploring diazoxide and continuous glucose monitoring as treatment for Glut1 deficiency syndrome

…, EL Connor, DA Hsu, RJ Fenske… - Annals of Clinical …, 2021 - Wiley Online Library
Glut1 deficiency syndrome is caused by SLC2A1 mutations on chromosome 1p34.2 that
impairs glucose transport across the blood–brain barrier resulting in hypoglycorrhachia and …